Related references
Note: Only part of the references are listed.Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion systematic review and meta-analysis of randomised trials
Gregoire Boulouis et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial
Daniel F. Hanley et al.
LANCET (2017)
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting A Scientific Statement From the American Heart Association
Amish N. Raval et al.
CIRCULATION (2017)
The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage
Jamil R. Dibu et al.
NEUROCRITICAL CARE (2016)
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
Jennifer A. Frontera et al.
NEUROCRITICAL CARE (2016)
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type
Duncan Wilson et al.
NEUROLOGY (2016)
Rapid reversal of haematoma expansion associated with vitamin K antagonists
John W. Eikelboom et al.
LANCET NEUROLOGY (2016)
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial
Thorsten Steiner et al.
LANCET NEUROLOGY (2016)
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage
Adnan I. Qureshi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results
Cheryl Carcel et al.
STROKE (2016)
Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
Jan C. Purrucker et al.
JAMA NEUROLOGY (2016)
Emergency Reversal of Novel Oral Anticoagulants Help Is on the Way
Stephan A. Mayer
JAMA NEUROLOGY (2016)
Reversal of Rivaroxaban-Induced Alterations on Hemostasis by Different Coagulation Factor Concentrates - In Vitro Studies With Steady and Circulating Human Blood -
Gines Escolar et al.
CIRCULATION JOURNAL (2015)
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbuchel et al.
EUROPACE (2015)
Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage
Joji B. Kuramatsu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re-appraisal
W. H. Dzik
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Idarucizumab for Dabigatran Reversal
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
J. Claude Hemphill et al.
STROKE (2015)
How I treat target-specific oral anticoagulant-associated bleeding
Deborah M. Siegal et al.
BLOOD (2014)
Laboratory Measurement of the Anticoagulant Activity of the Non-Vitamin K Oral Anticoagulants
Adam Cuker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban
Jack E. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Characteristics of Intracerebral Hemorrhage During Rivaroxaban Treatment Comparison With Those During Warfarin
Joji Hagii et al.
STROKE (2014)
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbuchel et al.
EUROPACE (2013)
Acute management of bleeding in patients on novel oral anticoagulants
Deborah M. Siegal et al.
EUROPEAN HEART JOURNAL (2013)
CURRENT CONCEPTS Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures
Todd H. Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Management of bleeding and coagulopathy following major trauma: an updated European guideline
Donat R. Spahn et al.
CRITICAL CARE (2013)
Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran
Joachim Stangier et al.
BLOOD COAGULATION & FIBRINOLYSIS (2012)
New direct oral anticoagulants - current therapeutic options and treatment recommendations for bleeding complications
Wolfgang Miesbach et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects
Elise S. Eerenberg et al.
CIRCULATION (2011)
Warfarin-related intraventricular hemorrhage Imaging and outcome
A. Biffi et al.
NEUROLOGY (2011)
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists A meta-analysis
Francesco Dentali et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage
Brett Cucchiara et al.
STROKE (2008)
Multiple imputation of discrete and continuous data by fully conditional specification
Stef van Buuren
STATISTICAL METHODS IN MEDICAL RESEARCH (2007)
Clinical interpretation and use of stroke scales
SE Kasner
LANCET NEUROLOGY (2006)
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
JJ Flibotte et al.
NEUROLOGY (2004)
Share Paper
